nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—obesity	0.858	1	CbGaD
Difluprednate—Nerve injury—Bupropion—obesity	0.00503	0.122	CcSEcCtD
Difluprednate—Iritis—Sibutramine—obesity	0.00331	0.0806	CcSEcCtD
Difluprednate—Conjunctival oedema—Topiramate—obesity	0.00252	0.0613	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LPIN1—obesity	0.0021	0.0229	CbGpPWpGaD
Difluprednate—Pregnancy—Bupropion—obesity	0.00193	0.0471	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HMGCS1—obesity	0.00185	0.0202	CbGpPWpGaD
Difluprednate—Iritis—Topiramate—obesity	0.00184	0.0448	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ACADM—obesity	0.0018	0.0196	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARD—obesity	0.00179	0.0195	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—NR1I3—obesity	0.00163	0.0178	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MAF—obesity	0.00155	0.0169	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—NR1I2—obesity	0.00149	0.0163	CbGpPWpGaD
Difluprednate—Endophthalmitis—Topiramate—obesity	0.00147	0.0357	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—obesity	0.00145	0.0158	CbGpPWpGaD
Difluprednate—Vision blurred—Phendimetrazine—obesity	0.00143	0.0349	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARD—obesity	0.00142	0.0154	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—obesity	0.00141	0.0153	CbGpPWpGaD
Difluprednate—Herpes simplex—Sibutramine—obesity	0.00137	0.0332	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—obesity	0.00136	0.0149	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HADH—obesity	0.00136	0.0149	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—obesity	0.00133	0.0145	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—obesity	0.0013	0.0141	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR1I3—obesity	0.00129	0.014	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—obesity	0.00129	0.014	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—obesity	0.00125	0.0136	CbGpPWpGaD
Difluprednate—Vision blurred—Phenylpropanolamine—obesity	0.00123	0.0298	CcSEcCtD
Difluprednate—Lacrimation increased—Bupropion—obesity	0.00119	0.029	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR1I2—obesity	0.00118	0.0128	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Topiramate—obesity	0.00118	0.0286	CcSEcCtD
Difluprednate—Dry eye—Sibutramine—obesity	0.00116	0.0283	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—obesity	0.00114	0.0125	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—obesity	0.00113	0.0123	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—obesity	0.00113	0.0123	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—FABP4—obesity	0.00106	0.0115	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—obesity	0.00103	0.0113	CbGpPWpGaD
Difluprednate—Photophobia—Bupropion—obesity	0.00103	0.0251	CcSEcCtD
Difluprednate—Vision blurred—Diethylpropion—obesity	0.00102	0.0248	CcSEcCtD
Difluprednate—Dry eye—Bupropion—obesity	0.00101	0.0247	CcSEcCtD
Difluprednate—Eye pain—Sibutramine—obesity	0.00101	0.0246	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—obesity	0.00101	0.011	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PNPLA3—obesity	0.000999	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—UCP1—obesity	0.000999	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—obesity	0.00098	0.0107	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—CLOCK—obesity	0.000944	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LIPE—obesity	0.000903	0.00984	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—obesity	0.000897	0.00977	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—obesity	0.000892	0.00972	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR2—obesity	0.000888	0.00967	CbGpPWpGaD
Difluprednate—Headache—Methamphetamine—obesity	0.000885	0.0216	CcSEcCtD
Difluprednate—Eye pain—Bupropion—obesity	0.000882	0.0215	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—obesity	0.000882	0.00961	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LEP—obesity	0.000873	0.00951	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RETN—obesity	0.000866	0.00943	CbGpPWpGaD
Difluprednate—Headache—Benzphetamine—obesity	0.000854	0.0208	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—CPT1A—obesity	0.000841	0.00917	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—obesity	0.000835	0.0091	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NAMPT—obesity	0.000825	0.00899	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—GH1—obesity	0.000805	0.00877	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CFD—obesity	0.000805	0.00877	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—AR—obesity	0.000784	0.00854	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—obesity	0.000779	0.00849	CbGpPWpGaD
Difluprednate—Headache—Phendimetrazine—obesity	0.000778	0.0189	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—obesity	0.00076	0.00828	CbGpPWpGaD
Difluprednate—Lacrimation increased—Topiramate—obesity	0.000759	0.0185	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—PLIN1—obesity	0.000757	0.00825	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—obesity	0.000755	0.00822	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SCD—obesity	0.000736	0.00802	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SREBF1—obesity	0.000735	0.00801	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—obesity	0.000726	0.00791	CbGpPWpGaD
Difluprednate—Weight increased—Sibutramine—obesity	0.000719	0.0175	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR2—obesity	0.000701	0.00764	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CYP26B1—obesity	0.000684	0.00746	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARD—obesity	0.00067	0.0073	CbGpPWpGaD
Difluprednate—Photophobia—Topiramate—obesity	0.000656	0.016	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ACADM—obesity	0.000654	0.00713	CbGpPWpGaD
Difluprednate—Dry eye—Topiramate—obesity	0.000646	0.0157	CcSEcCtD
Difluprednate—Headache—Phentermine—obesity	0.000636	0.0155	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—NCOA1—obesity	0.000627	0.00683	CbGpPWpGaD
Difluprednate—Weight increased—Bupropion—obesity	0.000626	0.0153	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SLC9A3—obesity	0.00062	0.00676	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—AR—obesity	0.00062	0.00675	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NCOA1—obesity	0.000608	0.00663	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—obesity	0.000607	0.00661	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—AR—obesity	0.000601	0.00655	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARA—obesity	0.000594	0.00647	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PCK1—obesity	0.000574	0.00625	CbGpPWpGaD
Difluprednate—Eye pain—Topiramate—obesity	0.000562	0.0137	CcSEcCtD
Difluprednate—Headache—Diethylpropion—obesity	0.000553	0.0135	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PPARGC1A—obesity	0.00055	0.00599	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SIRT1—obesity	0.000548	0.00597	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—obesity	0.000538	0.00586	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—obesity	0.000538	0.00586	CbGpPWpGaD
Difluprednate—Vision blurred—Orlistat—obesity	0.000536	0.013	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TCF7L2—obesity	0.000535	0.00583	CbGpPWpGaD
Difluprednate—Headache—Cimetidine—obesity	0.000526	0.0128	CcSEcCtD
Difluprednate—Vision blurred—Sibutramine—obesity	0.000519	0.0126	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—FOXO1—obesity	0.000512	0.00558	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000511	0.00556	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—obesity	0.00051	0.00556	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LPIN1—obesity	0.000508	0.00553	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—obesity	0.000496	0.0054	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—obesity	0.000491	0.00535	CbGpPWpGaD
Difluprednate—Prednicarbate—NR3C1—obesity	0.00048	0.0544	CrCbGaD
Difluprednate—Clocortolone—NR3C1—obesity	0.00048	0.0544	CrCbGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—obesity	0.000473	0.00515	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARA—obesity	0.00047	0.00512	CbGpPWpGaD
Difluprednate—Diflorasone—NR3C1—obesity	0.000454	0.0515	CrCbGaD
Difluprednate—Vision blurred—Bupropion—obesity	0.000452	0.011	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—obesity	0.000452	0.00492	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—obesity	0.000446	0.00486	CbGpPWpGaD
Difluprednate—Desoximetasone—NR3C1—obesity	0.000443	0.0502	CrCbGaD
Difluprednate—NR3C1—Circadian Clock—PPARA—obesity	0.000442	0.00482	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—PRL—obesity	0.000442	0.00482	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—obesity	0.000442	0.00482	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—obesity	0.000428	0.00467	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—obesity	0.000428	0.00466	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—obesity	0.000425	0.00463	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—obesity	0.000425	0.00463	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—obesity	0.00042	0.00458	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NAMPT—obesity	0.000415	0.00452	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—obesity	0.000404	0.0044	CbGpPWpGaD
Difluprednate—Weight increased—Topiramate—obesity	0.000399	0.00972	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—obesity	0.000393	0.00428	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—obesity	0.000388	0.00423	CbGpPWpGaD
Difluprednate—Flumethasone Pivalate—NR3C1—obesity	0.000381	0.0432	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000378	0.00412	CbGpPWpGaD
Difluprednate—Halobetasol Propionate—NR3C1—obesity	0.000375	0.0425	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.000374	0.00408	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SREBF1—obesity	0.00037	0.00403	CbGpPWpGaD
Difluprednate—Cortisone acetate—NR3C1—obesity	0.000369	0.0419	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CPT1A—obesity	0.000365	0.00398	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000364	0.00397	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GCK—obesity	0.000356	0.00388	CbGpPWpGaD
Difluprednate—Megestrol acetate—NR3C1—obesity	0.000356	0.0404	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—AGT—obesity	0.000353	0.00385	CbGpPWpGaD
Difluprednate—Amcinonide—NR3C1—obesity	0.000349	0.0395	CrCbGaD
Difluprednate—Fluticasone furoate—NR3C1—obesity	0.000342	0.0388	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TF—obesity	0.00034	0.0037	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—ADIPOQ—obesity	0.000339	0.0037	CbGpPWpGaD
Difluprednate—Mometasone—NR3C1—obesity	0.000332	0.0376	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—obesity	0.00033	0.0036	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—obesity	0.000329	0.00359	CbGpPWpGaD
Difluprednate—Pruritus—Orlistat—obesity	0.000328	0.00799	CcSEcCtD
Difluprednate—Rimexolone—NR3C1—obesity	0.000328	0.0372	CrCbGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—obesity	0.000326	0.00355	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SLC2A4—obesity	0.00032	0.00349	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000319	0.00348	CbGpPWpGaD
Difluprednate—Pruritus—Sibutramine—obesity	0.000318	0.00773	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NTRK2—obesity	0.000311	0.00339	CbGpPWpGaD
Difluprednate—Fluocinonide—NR3C1—obesity	0.000309	0.0351	CrCbGaD
Difluprednate—Beclomethasone—NR3C1—obesity	0.000309	0.0351	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—NCOA1—obesity	0.000306	0.00333	CbGpPWpGaD
Difluprednate—Fluocinolone Acetonide—NR3C1—obesity	0.0003	0.0341	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000294	0.0032	CbGpPWpGaD
Difluprednate—Clobetasol propionate—NR3C1—obesity	0.000293	0.0332	CrCbGaD
Difluprednate—Flunisolide—NR3C1—obesity	0.000293	0.0332	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCL2—obesity	0.000291	0.00317	CbGpPWpGaD
Difluprednate—Headache—Orlistat—obesity	0.000291	0.00708	CcSEcCtD
Difluprednate—Paramethasone—NR3C1—obesity	0.000289	0.0328	CrCbGaD
Difluprednate—Vision blurred—Topiramate—obesity	0.000288	0.00701	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ESR2—obesity	0.000287	0.00312	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—obesity	0.000286	0.00312	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SOCS1—obesity	0.000286	0.00311	CbGpPWpGaD
Difluprednate—Triamcinolone—BCHE—obesity	0.000283	0.0321	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—SOCS3—obesity	0.000282	0.00307	CbGpPWpGaD
Difluprednate—Fluorometholone—NR3C1—obesity	0.000282	0.032	CrCbGaD
Difluprednate—Headache—Sibutramine—obesity	0.000281	0.00685	CcSEcCtD
Difluprednate—Pruritus—Bupropion—obesity	0.000277	0.00674	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—PPARGC1A—obesity	0.000276	0.00301	CbGpPWpGaD
Difluprednate—Methylprednisolone—NR3C1—obesity	0.000273	0.0309	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—POMC—obesity	0.000262	0.00285	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—obesity	0.000253	0.00276	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AR—obesity	0.000253	0.00276	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—obesity	0.000253	0.00275	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LPL—obesity	0.000251	0.00274	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—FOXO1—obesity	0.00025	0.00272	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IFNG—obesity	0.000247	0.00269	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—APOBEC1—obesity	0.000246	0.00268	CbGpPWpGaD
Difluprednate—Headache—Bupropion—obesity	0.000245	0.00597	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARD—obesity	0.000245	0.00266	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000241	0.00263	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GNB3—obesity	0.000239	0.0026	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000239	0.0026	CbGpPWpGaD
Difluprednate—Betamethasone—CYP19A1—obesity	0.000232	0.0263	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—BDNF—obesity	0.000232	0.00253	CbGpPWpGaD
Difluprednate—Triamcinolone—NR3C1—obesity	0.00023	0.0261	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR1I3—obesity	0.000223	0.00243	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR0B2—obesity	0.000223	0.00243	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARA—obesity	0.000222	0.00242	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—obesity	0.000221	0.00241	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—obesity	0.000218	0.00237	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IRS2—obesity	0.000215	0.00235	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AGT—obesity	0.000215	0.00234	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LEP—obesity	0.000211	0.0023	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—obesity	0.000208	0.00226	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—NR3C1—obesity	0.000205	0.0233	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR1I2—obesity	0.000204	0.00222	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR2A—obesity	0.000196	0.00213	CbGpPWpGaD
Difluprednate—Betamethasone—NR3C1—obesity	0.000188	0.0213	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—IRS1—obesity	0.000188	0.00205	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CTNNBL1—obesity	0.000187	0.00203	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—obesity	0.000184	0.002	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—INS—obesity	0.00018	0.00196	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—obesity	0.000178	0.00194	CbGpPWpGaD
Difluprednate—Pruritus—Topiramate—obesity	0.000176	0.0043	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—obesity	0.000175	0.00191	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—obesity	0.000174	0.0019	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—obesity	0.000173	0.00188	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—obesity	0.000172	0.00187	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—obesity	0.000171	0.00187	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—obesity	0.000165	0.0018	CbGpPWpGaD
Difluprednate—Headache—Topiramate—obesity	0.000156	0.0038	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	0.000153	0.00166	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP19A1—obesity	0.000135	0.0153	CrCbGaD
Difluprednate—Triamcinolone—PTGS2—obesity	0.00013	0.0148	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—obesity	0.000129	0.00141	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PARP1—obesity	0.000128	0.00139	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR2—obesity	0.000121	0.00132	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARD—obesity	0.000118	0.00128	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	0.000116	0.00127	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	0.000114	0.00124	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT3—obesity	0.000113	0.00123	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOA1—obesity	0.000112	0.00122	CbGpPWpGaD
Difluprednate—Dexamethasone—NR3C1—obesity	0.000109	0.0124	CrCbGaD
Difluprednate—NR3C1—Gene Expression—NR0B2—obesity	0.000107	0.00117	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NR1I3—obesity	0.000107	0.00117	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—AR—obesity	0.000107	0.00117	CbGpPWpGaD
Difluprednate—Betamethasone—PTGS2—obesity	0.000107	0.0121	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	0.000106	0.00115	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	0.000105	0.00114	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—obesity	0.000104	0.00114	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP2E1—obesity	0.000101	0.0114	CrCbGaD
Difluprednate—NR3C1—Gene Expression—NR1I2—obesity	9.81e-05	0.00107	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—obesity	9.75e-05	0.00106	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	8.43e-05	0.000918	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARA—obesity	8.11e-05	0.000884	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6—obesity	7.87e-05	0.000857	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—obesity	7.35e-05	0.000801	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	6.8e-05	0.000741	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—obesity	6.7e-05	0.00073	CbGpPWpGaD
Difluprednate—Dexamethasone—PTGS2—obesity	6.21e-05	0.00705	CrCbGaD
Difluprednate—NR3C1—Gene Expression—PARP1—obesity	6.16e-05	0.000671	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	6.04e-05	0.000658	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR2—obesity	5.83e-05	0.000635	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOA1—obesity	5.37e-05	0.000586	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AR—obesity	5.15e-05	0.000561	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SIRT1—obesity	4.7e-05	0.000512	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PRKCD—obesity	4.07e-05	0.000444	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARA—obesity	3.9e-05	0.000425	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—obesity	3.82e-05	0.000416	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—obesity	3.54e-05	0.000385	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—obesity	3.23e-05	0.000352	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—obesity	2.91e-05	0.000317	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—obesity	1.84e-05	0.0002	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—obesity	1.28e-05	0.000139	CbGpPWpGaD
